Principles of pharmacology and toxicology also govern effects of chemicals on the endocrine system

Toxicological Sciences

Volumn 146, Issue 1, 2015, Pages 11-15

  Autrup, Herman ^a   Barile, Frank A ^b   Blaauboer, Bas J ^c   Degen, Gisela H ^d   Dekant, Wolfgang ^e   Dietrich, Daniel ^f   Domingo, Jose L ^g   Gori, Gio Batta ^h   Greim, Helmuth ⁱ   Hengstler, Jan G ^d   Kacew, Sam ^j   Marquardt, Hans ^k   Pelkonen, Olavi ^l   Savolainen, Kai ^m   Vermeulen, Nico P ⁿ  

^a AARHUS UNIVERSITY   (Denmark)

^b ST JOHN'S UNIVERSITY   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d TU DORTMUND UNIVERSITY   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF KONSTANZ   (Germany)

^g UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^h Health Policy Center   (United States)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF OTTAWA   (Canada)

^k Toxicology   (Germany)

^l UNIVERSITY OF OULU   (Finland)

^m FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

ⁿ VU UNIVERSITY AMSTERDAM   (Netherlands)

more..

Author keywords

Endocrine disruptors; Endocrine toxicology; Regulatory policy; Risk assessment

Indexed keywords

ENDOCRINE DISRUPTOR;

ARTICLE; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; HEALTH HAZARD; HORMONE ACTION; HUMAN; NONHUMAN; POLICY; RISK ASSESSMENT; UNITED NATIONS; WORLD HEALTH ORGANIZATION; DRUG EFFECTS; TOXICITY TESTING;

ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; HUMANS; TOXICITY TESTS;

EID: 84936761405     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv082     Document Type: Article

References (47)

1. Belli, P., Bellaton, C., Durand, J., Balleydier, S., Milhau, N., Mure, M., Mornex, J. F., Benahmed, M., and Le Jan, C., (2010). Fetal and neonatal exposure to the mycotoxin zearalenone induces phenotypic alterations in adult rat mammary gland. Food Chem. Toxicol., 48, 2818-2826.
2. Birnbaum, L. S., Bucher, J. R., Collman, G. W., Zeldin, D. C., Johnson, A. F., Schug, T. T., and Heindel, J. J. (2012). Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environ. Health Perspect., 120, 1640-1644.
3. Borgert, C. J., Baker, S. P., and Matthews, J. C. (2013). Potency matters: thresholds govern endocrine activity. Regul. Toxicol. Pharmacol., 67, 83-88.
4. Carmichael, N., Bausen, M., Boobis, A. R., Cohen, S. M., Embry, M., Fruijtier-Polloth, C., Greim, H., Lewis, R., Bette Meek, M. E., Mellor, H., et al. (2011). Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview. Crit. Rev. Toxicol., 41, 175-186.
5. Dekant, W., and Colnot, T. (2013). Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment. Toxicol. Lett., 223, 280-286.
6. Delclos, K. B., Weis, C. C., Bucci, T. J., Olson, G., Mellick, P., Sadovova, N., Latendresse, J. R., Thorn, B., and Newbold, R. R. (2009). Overlapping but distinct effects of genistein and ethinyl estradiol (EE(2)) in female Sprague-Dawley rats in multigenerational reproductive and chronic toxicity studies. Reprod. Toxicol., 27, 117-132.
7. Dietrich, D. R. (2010). Courage for simplification and imperfection in the 21st century assessment of 'Endocrine disruption'. ALTEX, 27, 264-278.
8. Dietrich, D. R., von Aulock, S., Marquardt, H., Blaauboer, B., Dekant, W., Kehrer, J., Hengstler, J., Collier, A., Gori, G. B., Pelkonen, O. P., et al. (2013). Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, wellestablished science and risk assessment principles. Toxicol. In Vitro, 27, 2110-2114.
9. EFSA (2013). Scientific opinion on the hazard assessment of endocrine disruptors: scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J., 11, 3132. European Food Safety Authority. Available at: http://www.efsa.europa.eu/en/efsajournal/doc/3132.pdf. Accessed April 13, 2015.
10. EFSA (2015). Opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J., 13, 3978. Accessed April 13, 2015.
11. EU-SCCS (2014). Memorandum on Endocrine Disruptors of the Scientific Committee on Consumer Safety (SCCS) adopted at its 8th plenary meeting on 16 December 2014.
12. Garwood, J. (2014). Do toxic editors trivialise hidden hazards? Lab Times, 3, 38-42. Available online at: http://www.labtimesarchiv.de/epaper/LT_14_03/files/assets/basic-html/page38.html.
13. Golden, R. J., Noller, K. L., Titus-Ernstoff, L., Kaufman, R. H., Mittendorf, R., Stillman, R., Reese, E. A. (1998). Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit. Rev. Toxicol., 28, 109-227.
14. Gore, A. C. (2013). Editorial: an international Riposte to Naysayers of endocrine-disrupting chemicals. Endocrinology, 154, 3955-3956.
15. Grandjean, P., and Ozonoff, D. (2013). Transparency and translation of science in a modern world. Environ. Health, 12, 70.
16. Greim, H. (2005). Chemicals with endocrine-disrupting potential: a threat to human health? Angew. Chem. Int. Ed. Engl., 44, 5568-5574.
17. Hengstler, J. (2014). When science becomes fiction-the mystery of endocrine disruptors, toxic editors, lobbyists and multimillionaires. Comment to 'Do toxic editors trivialize hidden hazards?' Labtimes, 3, 38-42; Lab Times 5, 45-46. Available at: http://www.labtimes.org/letters/Hengstler_Letter.pdf. Accessed April 13, 2015.
18. Hoover, R. N., Hyer, M., Pfeiffer, R. M., Adam, E., Bond, B., Cheville, A. L., Colton, T., Hartge, P., Hatch, E. E., Herbst, A. L., et al. (2011). Adverse health outcomes in women exposed in utero to diethylstilbestrol. N. Engl. J. Med., 365, 1304-1314.
19. Horel, S., and Bienkowski, B. (2013). Special report: scientists critical EU chemical policy have industry ties. Environmental Health News. Available at: http://www.environmentalhealthnews.org/ehs/news/2013/eu-conflict. Accessed April 13, 2015.
20. Iguchi, T., Hirokawa, M., and Takasugi, N. (1986). Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology, 42, 1-11.
21. Imperato-McGinley, J., Sanchez, R. S., Spencer, J. R., Yee, B., and Vaughan, E. D. (1992). Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology, 131, 1149-1156.
22. Klaassen, C. D. (Ed.) (2013). Casarett and Doull's Toxicology. The Basic Science of Poisons. McGraw-Hill Medical Publishing Division, New York.
23. Kortenkamp, A., and Faust, M. (2010). Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment. Int. J. Androl., 33, 463-474.
24. Lamb, J. C., Boffetta, P., Foster, W. G., Goodman, J. E., Hentz, K. L., Rhomberg, L. R., Staveley, J., Swaen, G., Van Der Kraak, G., and Williams, A. L. (2014). Critical comments on the WHOUNEP State of the Science of Endocrine Disrupting Chemicals-2012. Regul. Toxicol. Pharmacol., 69, 22-40.
25. Latendresse, J. R., Bucci, T. J., Olson, G., Mellick, P., Weis, C. C., Thorn, B., Newbold, R. R., and Delclos, K. B. (2009). Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats. Reprod. Toxicol., 28, 342-353.
26. Lehman-McKeeman, L. D., and Kaminski, N. E. (2013). The hazards of playing it safe: perspectives on how the society of toxicology should contribute to discussions on timely issues of human and environmental safety. Toxicol. Sci., 136, 1-3.
27. Mirmira, P., and Evans-Molina, C. (2014). Bisphenol A, obesity, and type 2 diabetes mellitus: genuine concern or unnecessary preoccupation? Transl. Res., 164, 13-21.
28. Myers, J. P., vom Saal, F. S., Akingbemi, B. T., Arizono, K., Belcher, S., Colborn, T., Chahoud, I., Crain, D. A., Farabollini, F., Guillette, L. J., Jr., et al. (2009). Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ. Health Perspect., 117, 309-315.
29. Newbold, R. R., Jefferson, W. N., Padilla-Burgos, E., and Bullock, B. C. (1997). Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis, 18, 2293-2298.
30. OECD (2013). Guidance document on developing and assessing adverse outcome pathways, Serieas on Testing and Assessment No. 184. Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono%282013%296&doclanguage=en. Accessed February 13, 2015.
31. Open-Letter (2013). Draft regulation on endocrine active chemicals-Open letter to Prof. Ann Glover, Chief Scientific Advisor to the President of the European Commission signed by 76 international scientists. Available at: http://www.toxikologie.uni-wuerzburg.de/fileadmin/03250200/news/Letter_to_Prof_Glover.pdf. Accessed April 13, 2015.
32. Palmer, J. R., Herbst, A. L., Noller, K. L., Boggs, D. A., Troisi, R., Titus-Ernstoff, L., Hatch, E. E., Wise, L. A., Strohsnitter, W. C., and Hoover, R. N. (2009). Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ. Health, 8, 37.
33. Reinen, J., Kalma, L. L., Begheijn, S., Heus, F., Commandeur, J. N., and Vermeulen, N. P. (2011). Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone. Xenobiotica, 41, 59-70.
34. Reinen, J., and Vermeulen, N. P. (2015). Biotransformation of endocrine disrupting compounds by selected phase I and phase II enzymes-formation of estrogenic and chemically reactive metabolites by cytochromes P450 and sulfotransferases. Curr. Med. Chem., 22, 500-527.
35. Safe, S. H. (1995). Environmental and dietary estrogens and human health: is there a problem? Environ. Health Perspect., 103, 346-351.
36. Safe, S.H. (2000). Endocrine disruptors and human health-is there a problem? An update. Environ. Health Perspect., 108, 487-493.
37. Testai, E., Galli, C. L., Dekant, W., Marinovich, M., Piersma, A. H., and Sharpe, R. M. (2013). A plea for risk assessment of endocrine disrupting chemicals. Toxicology, 314, 51-59.
38. Tyl, R. W., Myers, C. B., Marr, M. C., Castillo, N. P., Veselica, M. M., Joiner, R. L., Dimond, S. S., Van Miller, J. P., Stropp, G. D., Waechter, J. M., Jr., et al. (2008a). One-generation reproductive toxicity study of dietary 17beta-estradiol (E2; CAS No. 50-28-2) in CD-1 (Swiss) mice. Reprod. Toxicol., 25, 144-160.
39. Tyl, R. W., Myers, C. B., Marr, M. C., Sloan, C. S., Castillo, N. P., Veselica, M. M., Seely, J. C., Dimond, S. S., Van Miller, J. P., Shiotsuka, R. S., et al. (2008b). Two-generation reproductive toxicity evaluation of dietary 17beta-estradiol (E2; CAS No. 50-28-2) in CD-1 (Swiss) mice. Toxicol. Sci., 102, 392-412.
40. van Liempd, S. M., Kool, J., Niessen, W. M., van Elswijk, D. E., Irth, H., and Vermeulen, N. P. (2006). On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators. Drug Metab. Dispos., 34, 1640-1649.
41. Vandenberg, L. N., Chahoud, I., Padmanabhan, V., Paumgartten, F. J., and Schoenfelder, G. (2010). Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ. Health Perspect., 118, 1051-1054.
42. Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Jr., Lee, D. H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012). Hormones and endocrinedisrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev., 33, 378-455.
43. Vandenberg, L. N., Maffini, M. V., Sonnenschein, C., Rubin, B. S., and Soto, A. M. (2009). Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev., 30, 75-95.
44. WHO/UNEP (2002). Global assessment of the state-of-thescience of endocrine disruptors. WHO/PCS/EDC/02.2, World Health Organisation, Geneva.
45. WHO/UNEP (2012). State of the science of endocrine disrupting chemicals-2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and WHO. World Health Organisation, Geneva. Available at: http://www.who.int/ceh/publications/endocrine/en/. Accessed April 13, 2015.
46. Zhao, F., Li, R., Xiao, S., Diao, H., Viveiros, M. M., Song, X., and Ye, X. (2013). Postweaning exposure to dietary zearalenone, a mycotoxin, promotes premature onset of puberty and disrupts early pregnancy events in female mice. Toxicol. Sci., 132, 431-442.
47. Zoeller, R. T., Bergman, A., Becher, G., Bjerregaard, P., Bornman, R., Brandt, I., Iguchi, T., Jobling, S., Kidd, K. A., Kortenkamp, A., et al. (2014). A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ. Health, 14, 118.